metastatic HER2-positive Adenocarcinoma of the Stomach

DBCOND0144313Gastrointestinal Tract Disorders Neoplasms

metastatic HER2-positive Adenocarcinoma of the Stomach is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Classified under: Gastrointestinal Tract Disorders
Neoplasms
Neoplasms, Glandular and Epithelial
Indicated drugs: Pembrolizumab

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

Which approved drugs for metastatic HER2-positive Adenocarcinoma of the Stomach share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account